Top Oil Service Companies To Invest In 2014

It's been more than three years since the spill at the Macondo well in the Gulf of Mexico, and day by day the prospects for oil exploration there seem to get better. A recent report by Wood MacKenzie shows that production in the Gulf went up 6% last year, and another 4% is expected this year. By 2018, the research group�believes�that the Gulf will be back to its pre-Macondo-spill high in�production�of 2 million barrels per day. �

For this to happen, though, exploration and production companies will need to spend a pretty penny. Between now and 2015, E&P companies are expected to spend somewhere around $20 billion. In this video, fool.com contributor Tyler Crowe looks at what this could mean for oil services companies that specialize in offshore regions such as the Gulf.

Top Oil Service Companies To Invest In 2014: ParkerVision Inc.(PRKR)

Parkervision, Inc. engages in the design, development, and sale of proprietary radio frequency (RF) technologies and products for use in semiconductor circuits for wireless communication products in the United States. The company provides its wireless technologies for processing RF waveforms in wireless applications. Its technology applies to transmit and receive functions of a radio transceiver. Its transmit portion of the technology, Direct2Power, enables the transformation of a baseband data signal to an RF carrier waveform at the desired power output level in a single unified operation. The company?s receiver portion of the technology, Direct2Data, enables the direct conversion of an RF carrier to a baseband data signal. It also provides engineering consulting and design services to its customers to assist them in developing prototypes and/or products incorporating its technologies. The company licenses its intellectual property and sells integrated circuits for incor poration into wireless devices designed by its customers. It primarily focuses on incorporating its technologies into mobile handsets, as well as to other wireless products that are related to networks serving mobile handsets, such as data cards, femtocells, and machine-to-machine and embedded applications. The company?s technology is also used in non-cellular radio applications comprising military radios. In addition, Parkervision, Inc. develops wireless radio modules for mobile handset and data card applications through a joint development and marketing agreement with LG Innotek Co., Ltd. It serves mobile handset manufacturers and their chipset suppliers in the mobile handset industry. The company was founded in 1989 and is headquartered in Jacksonville, Florida.

Top Oil Service Companies To Invest In 2014: Blackrock Global (BOE)

BlackRock Global Opportunities Equity Trust is a closed ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets across the globe. The fund invests in the stocks of companies operating across diversified sectors. It primarily invests in all cap companies. The fund benchmarks the performance of its portfolio against the S&P Global Broad Market Index. BlackRock Global Opportunities Equity Trust was formed on May 31, 2005 and is domiciled in the United States.

Top 5 High Dividend Companies For 2014: Immunomedics Inc.(IMMU)

Immunomedics, Inc., a biopharmaceutical company, engages in the research, development, manufacture, and marketing of monoclonal, antibody-based products for the treatment of cancer, autoimmune, and other serious diseases in the United States and Europe. The company?s products include epratuzumab, a Phase III clinical trail product for the treatment of systemic lupus erythematosus and non-Hodgkin?s lymphoma; Veltuzumab, a Phase I/II clinical study completed product for the treatment of patients with non-Hodgkin?s lymphoma, immune thrombocytopenic purpura, and chronic lymphocytic leukemia; Yttrium Y 90 Clivatuzumab tetraxetan, a humanized monoclonal antibody for pancreatic cancer that is in Phase Ib/II clinical trail; and Yttrium Y 90 epratuzumab tetraxetan, a Phase I/II clinical study product for patients with non-Hodgkin?s lymphoma. Its early phase clinical trial products comprise Milatuzumab, a transmembrane protein product for antibody-drug conjugate therapy. The com pany also develops Dock-and-Lock methodology for making fusion proteins and multifunctional antibodies, as well as a new method of delivering imaging and therapeutic agents selectively to disease, primarily different solid cancers. In addition, it markets and sells a diagnostic product, LeukoScan, which is used to treat infection and inflammation in bones for patients with suspected osteomyelitis, including patients with diabetic foot ulcers. Immunomedics, Inc. has a license and collaboration agreement with Nycomed GmbH to develop, manufacture, and commercialize veltuzumab in the subcutaneous formulation for the treatment of various non-cancer indications; and a partnership and cross-licensing agreement with Alexis Biotech Ltd., to develop vaccines against cancers that include melanoma and chronic lymphocytic leukemia, and infectious diseases, such as AIDS. The company was founded in 1982 and is headquartered in Morris Plains, New Jersey.

Advisors' Opinion:

• [By Roberto Pedone]

  Immunomedics (IMMU) is a biopharmaceutical company focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases. This stock closed up 3.2% at $2.56 on Thursday.

  Thursday's Range: $2.46-$2.61
  
  52-Week Range: $2.11-$3.76
  
  Volume: 426,000
  
  Three-Month Average Volume: 436,776

  From a technical perspective, IMMU bounced higher here right off its 50-day moving average of $2.46 with decent upside volume. This move is starting to push shares of IMMU into breakout territory, since it's flirting with taking out a key downtrend line that dates back to February. That breakout will hit if IMMU manages to take out some near-term overhead resistance levels at $2.56 to $2.62 and then once it clears more resistance at $2.75 with high volume.

  Traders should now look for long-biased trades in IMMU as long as it's trending above its 50-day at $2.46 or above some key near-term support levels at $2.40 to $2.30 and then once it sustains a move or close above those breakout levels with volume that hits near or above 436,776 shares. If that breakout hits soon, then IMMU will set up to re-test or possibly take out its next major overhead resistance levels at $3 to $3.14. Any high-volume move above $3.14 will then put $3.23 to $3.40 into range for shares of IMMU.